In regard to Anagnostopoulos et al.: In vivo thermoluminescence dosimetry dose verification of transperinal (192)Ir high dose rate brachytherapy using CT-based planning for the treatment of prostate cancer (Int J Radiat Oncol Biol Phys 2003;57:1183-1191).
Duggan
Lisa
L
Bucci
Joseph
J
Kron
Tomas
T
D001918:Brachytherapy / Q000379:methods*; D003300:Copper; D006801:Humans; D007496:Iridium Radioisotopes / Q000627:therapeutic use; D018020:Lithium Compounds; D008274:Magnesium; D008297:Male; D010758:Phosphorus; D011471:Prostatic Neoplasms / Q000532:radiotherapy*; D011879:Radiotherapy Dosage; D011880:Radiotherapy Planning, Computer-Assisted / Q000379:methods; D013819:Thermoluminescent Dosimetry / Q000379:methods*
D007496:Iridium Radioisotopes; C474232:LiF-Mg,Cu,P; D018020:Lithium Compounds; D010758:Phosphorus; D003300:Copper; D008274:Magnesium